Procter & Gamble Hygiene and Health Care (500459) Q4 25/26 earnings summary

Executive summary

• Audited financial results for the year ended March 31, 2026, were approved and published, with an unmodified audit opinion from statutory auditors.

• Board recommended a final dividend of ₹60 per equity share, subject to AGM approval.

Financial highlights

• Revenue from operations for FY26 was ₹428,159 lakhs, compared to ₹336,811 lakhs for the nine months ended March 31, 2025.

• Net profit for FY26 was ₹86,079 lakhs, up from ₹62,953 lakhs for the prior nine-month period.

• Earnings per share (EPS) for FY26 stood at ₹263.86, compared to ₹196.11 for the previous period.

Outlook and guidance

• Dividend of ₹60 per share recommended, to be paid on or before September 18, 2026, upon AGM approval.

• Company will monitor the impact of new labour codes and update estimates as state rules are notified.